Peter Helt Jacobsen Haahr

Largest profit: Novo Nordisk Pharmatech A/S (2017) '103,665 DKK

Most equity: Novo Nordisk Pharmatech A/S (2017) '528,953 DKK

• Novo Nordisk Pharmatech A/S

  Active

  
  

  Board member (2012-09-03 - 2016-10-31)

• NOVO NORDISK PHARMA OPERATIONS A/S

  Active

  
  

  Director (2010-12-17 - 2013-09-01)

• SONION HOLDCO A/S

  Active

  
  

  Board member (2019-02-22 - 2021-08-16)

• HOUSE OF DENMARK A/S

  Active

  
  

  Board member (2014-05-12 - present)

• World Diabetes Foundation

  Active

  
  

  Ultimate beneficial owner (2023-01-01 - present)

• House of Strategy

  Inactive

  
  

  Legal owner (2016-01-01 - 2016-12-31)